2009
DOI: 10.4161/pri.3.4.9549
|View full text |Cite
|
Sign up to set email alerts
|

Role of prions in neuroprotection and neurodegeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 39 publications
0
8
0
Order By: Relevance
“…Even the evidence of preclinical downregulation of PrP C in several disease models was discussed basically as a possible neuroprotective event, on the grounds that it would provide less substrate for conformational conversion and thus for disease progress (Mays et al, 2014 ). In fact, gain- and loss-of-function components are not mutually exclusive, and the abundant evidence for neuroprotective effects of PrP C (Zamponi and Stys, 2009 ; Martins et al, 2010 ; Biasini et al, 2012 ; Onodera et al, 2014 ; Zeng et al, 2015 ) concurs with the hypothesis that the early and robust loss of PrP C may be involved in the pathogenesis of TSEs. In turn, whereas PrP C has been identified as a pathogenic receptor for AβO in models of AD, binding of the prion protein to hop/STI1 also mediates neuroprotection against AβO neurotoxicity (Ostapchenko et al, 2013 ), which reinforce the interest in physiological properties of PrP C .…”
Section: Corruption Of Prion Protein-mediated Signaling and The Scaffmentioning
confidence: 77%
“…Even the evidence of preclinical downregulation of PrP C in several disease models was discussed basically as a possible neuroprotective event, on the grounds that it would provide less substrate for conformational conversion and thus for disease progress (Mays et al, 2014 ). In fact, gain- and loss-of-function components are not mutually exclusive, and the abundant evidence for neuroprotective effects of PrP C (Zamponi and Stys, 2009 ; Martins et al, 2010 ; Biasini et al, 2012 ; Onodera et al, 2014 ; Zeng et al, 2015 ) concurs with the hypothesis that the early and robust loss of PrP C may be involved in the pathogenesis of TSEs. In turn, whereas PrP C has been identified as a pathogenic receptor for AβO in models of AD, binding of the prion protein to hop/STI1 also mediates neuroprotection against AβO neurotoxicity (Ostapchenko et al, 2013 ), which reinforce the interest in physiological properties of PrP C .…”
Section: Corruption Of Prion Protein-mediated Signaling and The Scaffmentioning
confidence: 77%
“…It is becoming increasingly clear that cellular prion protein is an important neuromodulator [37], but there have been few studies showing its possible role in mood disorders. Our data demonstrate that the PrP −/− mice exhibit an increase in immobility time compared to wild-type mice in both the FST and in the TST.…”
Section: Discussionmentioning
confidence: 99%
“…This abnormal protein accumulates in the brain, forming polymeric aggregates that disrupt synapses, leading to loss of dendrites and finally neuronal death (Soto and Satani, 2011 ). Although this pathological role of misfolded PrP C has been established and studied extensively, the function of PrP C in the normal brain remains largely unknown (Linden et al, 2008 ; Zamponi and Stys, 2009 ; Stys et al, 2012 ; Black et al, 2014 ). Initial studies with PrP-null mice revealed a mild pathology, such as a slight impairment of spatial learning (Collinge et al, 1994 ; Manson et al, 1995 ), but otherwise normal development (Büeler et al, 1992 ; Manson et al, 1994 ; Criado et al, 2005 ).…”
Section: Introductionmentioning
confidence: 99%